Showing results (1-10 of 1,071) with videos related to
Sort By:
Pageof 108
The Journal of Clinical Investigation|October 2, 2014
The contributory role of gut microbiota in cardiovascular diseaseW H Wilson Tang, Stanley L HazenTranslational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2016
Microbiome, trimethylamine N-oxide, and cardiometabolic diseaseW H Wilson Tang, Stanley L HazenProgress in Cardiovascular Diseases|July 25, 2012
Translating metabolomics to cardiovascular biomarkersTodd Senn, Stanley L Hazen, W H Wilson TangCirculation Research|April 1, 2017
Gut Microbiota in Cardiovascular Health and DiseaseW H Wilson Tang, Takeshi Kitai, Stanley L HazenKidney International|June 11, 2015
Protein carbamylation and cardiovascular diseaseFrederik H Verbrugge, W H Wilson Tang, Stanley L HazenNature Reviews. Cardiology|November 10, 2018
Dietary metabolism, the gut microbiome, and heart failureW H Wilson Tang, Daniel Y Li, Stanley L HazenCirculation. Heart Failure|August 18, 2012
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular eventsMatthias Dupont, Yuping Wu, Stanley L Hazen, et al.The American Journal of Cardiology|December 11, 2012
Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic statusW H Wilson Tang, Naveed Iqbal, Yuping Wu, et al.Cardiovascular Diabetology|August 22, 2021
Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetesMarco Witkowski, Yuping Wu, Stanley L Hazen, et al.American Heart Journal|November 29, 2016
Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status IndexVichai Senthong, Yuping Wu, Stanley L Hazen, et al.Pageof 108